Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-000610
Filing Date
2015-04-30
Accepted
2015-04-30 08:15:38
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20150331x10q.htm 10-Q 1414974
2 EX-10.1 alks-20150331ex101ef594d.htm EX-10.1 134680
3 EX-10.2 alks-20150331ex102f3d912.htm EX-10.2 165222
4 EX-31.1 alks-20150331ex311143b9f.htm EX-31.1 39587
5 EX-31.2 alks-20150331ex31204c77c.htm EX-31.2 34879
6 EX-32.1 alks-20150331ex321896775.htm EX-32.1 17635
  Complete submission text file 0001558370-15-000610.txt   8830090

Data Files

Seq Description Document Type Size
7 EX-101.INS alks-20150331.xml EX-101.INS 1487050
8 EX-101.SCH alks-20150331.xsd EX-101.SCH 34563
9 EX-101.CAL alks-20150331_cal.xml EX-101.CAL 69867
10 EX-101.DEF alks-20150331_def.xml EX-101.DEF 97171
11 EX-101.LAB alks-20150331_lab.xml EX-101.LAB 385501
12 EX-101.PRE alks-20150331_pre.xml EX-101.PRE 258792
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 15815354
SIC: 2834 Pharmaceutical Preparations